Forum: Clinical Trials
07-15-2013, 08:36 PM
|
Replies: 0
Views: 9,067
TDM1 trial (KATHERINE) Phase III
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following...
|